Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

11 C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia.

Nicastro N, Surendranathan A, Mak E, Rowe JB, O'Brien JT.

Ann Clin Transl Neurol. 2019 Sep 10. doi: 10.1002/acn3.50877. [Epub ahead of print]

2.

Team-based outpatient early palliative care: a complex cancer intervention.

Zimmermann C, Ryan S, Hannon B, Saltman A, Rodin G, Mak E, Al-Awamer A, Lau J.

BMJ Support Palliat Care. 2019 Aug 12. pii: bmjspcare-2019-001903. doi: 10.1136/bmjspcare-2019-001903. [Epub ahead of print]

PMID:
31406013
3.

Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance.

Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, Mak E, Su L, O'Brien JT, Rowe JB.

J Neurosci. 2019 Sep 4;39(36):7218-7226. doi: 10.1523/JNEUROSCI.2574-18.2019. Epub 2019 Jul 18.

4.

Delineating the topography of amyloid-associated cortical atrophy in Down syndrome.

Mak E, Padilla C, Annus T, Wilson LR, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Menon DK, Nestor PJ, Zaman SH, Holland AJ.

Neurobiol Aging. 2019 Aug;80:196-202. doi: 10.1016/j.neurobiolaging.2019.02.018. Epub 2019 Mar 5.

PMID:
31207551
5.

Inflammation and cerebral small vessel disease: A systematic review.

Low A, Mak E, Rowe JB, Markus HS, O'Brien JT.

Ageing Res Rev. 2019 Aug;53:100916. doi: 10.1016/j.arr.2019.100916. Epub 2019 Jun 10. Review.

PMID:
31181331
6.

Imaging Tau, Neuroinflammation, and Aβ in Dementia With Lewy Bodies: A Deep-Phenotyping Case Report.

Mak E, Surendranathan A, Nicastro N, Aigbirhio F, Rowe J, O'Brien J.

Mov Disord Clin Pract. 2018 Nov 8;6(1):77-80. doi: 10.1002/mdc3.12689. eCollection 2019 Jan. No abstract available.

7.

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.

Mak E, Bethlehem RAI, Romero-Garcia R, Cervenka S, Rittman T, Gabel S, Surendranathan A, Bevan-Jones RW, Passamonti L, Vázquez Rodríguez P, Su L, Arnold R, Williams GB, Hong YT, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Alzheimers Dement (Amst). 2018 Sep 17;10:678-687. doi: 10.1016/j.dadm.2018.08.005. eCollection 2018.

8.

Early microglial activation and peripheral inflammation in dementia with Lewy bodies.

Surendranathan A, Su L, Mak E, Passamonti L, Hong YT, Arnold R, Vázquez Rodríguez P, Bevan-Jones WR, Brain SAE, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Brain. 2018 Dec 1;141(12):3415-3427. doi: 10.1093/brain/awy265.

9.

Expression of murine muscle-enriched A-type lamin-interacting protein (MLIP) is regulated by tissue-specific alternative transcription start sites.

Cattin ME, Deeke SA, Dick SA, Verret-Borsos ZJA, Tennakoon G, Gupta R, Mak E, Roeske CL, Weldrick JJ, Megeney LA, Burgon PG.

J Biol Chem. 2018 Dec 21;293(51):19761-19770. doi: 10.1074/jbc.RA118.003758. Epub 2018 Nov 2.

PMID:
30389785
10.

Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.

Mak E, Donaghy PC, McKiernan E, Firbank MJ, Lloyd J, Petrides GS, Thomas AJ, O'Brien JT.

Neurobiol Aging. 2019 Jan;73:74-81. doi: 10.1016/j.neurobiolaging.2018.09.004. Epub 2018 Sep 12.

PMID:
30339962
11.

Substantial variation across geographic regions in the obesity prevalence among 6-8 years old Hungarian children (COSI Hungary 2016).

Erdei G, Bakacs M, Illés É, Nagy B, Kaposvári C, Mák E, Nagy ES, Cserháti Z, Kovács VA.

BMC Public Health. 2018 May 9;18(1):611. doi: 10.1186/s12889-018-5530-6.

12.

[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.

Passamonti L, Rodríguez PV, Hong YT, Allinson KSJ, Bevan-Jones WR, Williamson D, Jones PS, Arnold R, Borchert RJ, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB.

Neurology. 2018 May 29;90(22):e1989-e1996. doi: 10.1212/WNL.0000000000005610. Epub 2018 Apr 27.

13.

Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.

Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT.

J Neurol. 2018 Jul;265(7):1528-1539. doi: 10.1007/s00415-018-8873-0. Epub 2018 Apr 25.

PMID:
29696499
14.

Patient-Reported Functional Status in Outpatients With Advanced Cancer: Correlation With Physician-Reported Scores and Survival.

Popovic G, Harhara T, Pope A, Al-Awamer A, Banerjee S, Bryson J, Mak E, Lau J, Hannon B, Swami N, Le LW, Zimmermann C.

J Pain Symptom Manage. 2018 Jun;55(6):1500-1508. doi: 10.1016/j.jpainsymman.2018.02.015. Epub 2018 Feb 26.

PMID:
29496534
15.

Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease.

Stefaniak JD, Su L, Mak E, Sheikh-Bahaei N, Wells K, Ritchie K, Waldman A, Ritchie CW, O'Brien JT.

Alzheimers Dement. 2018 Feb;14(2):253-258. doi: 10.1016/j.jalz.2017.08.017. Epub 2017 Nov 21.

PMID:
29156222
16.

Water-effect ratio of copper and its application on setting site-specific water quality criteria for protecting marine ecosystems of Hong Kong.

Bao VWW, Ho KKY, Lai KKY, Mak YKY, Mak EPY, Zhou GJ, Giesy JP, Leung KMY.

Environ Sci Pollut Res Int. 2018 Feb;25(4):3170-3182. doi: 10.1007/s11356-017-9428-0. Epub 2017 Jun 28.

PMID:
28656578
17.

Structural Covariance Networks in Children with Autism or ADHD.

Bethlehem RAI, Romero-Garcia R, Mak E, Bullmore ET, Baron-Cohen S.

Cereb Cortex. 2017 Aug 1;27(8):4267-4276. doi: 10.1093/cercor/bhx135.

18.

Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.

Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Mollenhauer B, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.

Neurobiol Aging. 2017 Jul;55:78-90. doi: 10.1016/j.neurobiolaging.2017.03.012. Epub 2017 Mar 16.

19.

Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer's disease.

Habib M, Mak E, Gabel S, Su L, Williams G, Waldman A, Wells K, Ritchie K, Ritchie C, O'Brien JT.

Ageing Res Rev. 2017 Jul;36:88-104. doi: 10.1016/j.arr.2017.03.004. Epub 2017 Mar 22. Review.

PMID:
28342882
20.

Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.

Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, Ding YS, Adam M, Aasly J, Wszolek ZK, Farrer M, Sossi V, Stoessl AJ.

Lancet Neurol. 2017 May;16(5):351-359. doi: 10.1016/S1474-4422(17)30056-X. Epub 2017 Mar 20.

21.

In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.

Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O'Brien JT.

Ageing Res Rev. 2017 Jul;36:50-63. doi: 10.1016/j.arr.2017.03.002. Epub 2017 Mar 15. Review.

PMID:
28315409
22.

Benefit-finding and effect on caregiver depression: A double-blind randomized controlled trial.

Cheng ST, Mak EPM, Fung HH, Kwok T, Lee DTF, Lam LCW.

J Consult Clin Psychol. 2017 May;85(5):521-529. doi: 10.1037/ccp0000176. Epub 2017 Mar 13.

PMID:
28287803
23.

18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.

Passamonti L, Vázquez Rodríguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB.

Brain. 2017 Mar 1;140(3):781-791. doi: 10.1093/brain/aww340.

24.

Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease.

Foo H, Mak E, Chander RJ, Ng A, Au WL, Sitoh YY, Tan LC, Kandiah N.

Neuroimage Clin. 2016 Dec 12;14:37-42. doi: 10.1016/j.nicl.2016.12.008. eCollection 2017.

25.

Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.

Mak E, Gabel S, Su L, Williams GB, Arnold R, Passamonti L, Vazquez Rodríguez P, Surendranathan A, Bevan-Jones WR, Rowe JB, O'Brien JT.

Int Psychogeriatr. 2017 Apr;29(4):545-555. doi: 10.1017/S1041610216002143. Epub 2017 Jan 16.

26.

Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.

Bevan-Jones WR, Surendranathan A, Passamonti L, Vázquez Rodríguez P, Arnold R, Mak E, Su L, Coles JP, Fryer TD, Hong YT, Williams G, Aigbirhio F, Rowe JB, O'Brien JT.

BMJ Open. 2017 Jan 7;7(1):e013187. doi: 10.1136/bmjopen-2016-013187.

27.

Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.

Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Sitoh YY, Tan LC, Kandiah N.

Eur J Neurol. 2017 Feb;24(2):341-348. doi: 10.1111/ene.13205. Epub 2016 Dec 10.

PMID:
27943468
28.

Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes.

Mak E, Gabel S, Mirette H, Su L, Williams GB, Waldman A, Wells K, Ritchie K, Ritchie C, O'Brien J.

Ageing Res Rev. 2017 May;35:250-264. doi: 10.1016/j.arr.2016.10.001. Epub 2016 Oct 21. Review.

29.

Neuroinflammatory and morphological changes in late-life depression: the NIMROD study.

Su L, Faluyi YO, Hong YT, Fryer TD, Mak E, Gabel S, Hayes L, Soteriades S, Williams GB, Arnold R, Passamonti L, Rodríguez PV, Surendranathan A, Bevan-Jones RW, Coles J, Aigbirhio F, Rowe JB, O'Brien JT.

Br J Psychiatry. 2016 Dec;209(6):525-526. Epub 2016 Oct 6.

30.

The segregated connectome of late-life depression: a combined cortical thickness and structural covariance analysis.

Mak E, Colloby SJ, Thomas A, O'Brien JT.

Neurobiol Aging. 2016 Dec;48:212-221. doi: 10.1016/j.neurobiolaging.2016.08.013. Epub 2016 Aug 24.

31.

[Support of diabetes dietary management and self-management using mobile applications].

Szálka B, Kósa I, Vassányi I, Mák E.

Orv Hetil. 2016 Jul;157(29):1147-53. doi: 10.1556/650.2016.30458. Review. Hungarian.

PMID:
27426463
32.

Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.

Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Tan L, Kandiah N.

Parkinsonism Relat Disord. 2016 Oct;31:34-40. doi: 10.1016/j.parkreldis.2016.06.019. Epub 2016 Jun 30.

PMID:
27397577
33.

Dissociated Accumbens and Hippocampal Structural Abnormalities across Obesity and Alcohol Dependence.

Mole TB, Mak E, Chien Y, Voon V.

Int J Neuropsychopharmacol. 2016 Sep 21;19(9). pii: pyw039. doi: 10.1093/ijnp/pyw039. Print 2016 Sep.

34.

Longitudinal diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease.

Firbank MJ, Watson R, Mak E, Aribisala B, Barber R, Colloby SJ, He J, Blamire AM, O'Brien JT.

Parkinsonism Relat Disord. 2016 Mar;24:76-80. doi: 10.1016/j.parkreldis.2016.01.003. Epub 2016 Jan 6.

PMID:
26792342
35.

Persistent Diarrhea after Celiac Plexus Block in a Pancreatic Cancer Patient: Case Report and Literature Review.

Yang A, Brown J, Mak E.

J Palliat Med. 2016 Jan;19(1):83-6. doi: 10.1089/jpm.2015.0117. Epub 2015 Sep 18. Review.

PMID:
26381724
36.

Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation.

Cattin ME, Wang J, Weldrick JJ, Roeske CL, Mak E, Thorn SL, DaSilva JN, Wang Y, Lusis AJ, Burgon PG.

J Biol Chem. 2015 Oct 30;290(44):26699-714. doi: 10.1074/jbc.M115.678433. Epub 2015 Sep 10.

37.

Differential Atrophy of Hippocampal Subfields: A Comparative Study of Dementia with Lewy Bodies and Alzheimer Disease.

Mak E, Su L, Williams GB, Watson R, Firbank M, Blamire A, O'Brien J.

Am J Geriatr Psychiatry. 2016 Feb;24(2):136-43. doi: 10.1016/j.jagp.2015.06.006. Epub 2015 Jun 25.

PMID:
26324541
38.

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.

Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.

Brain. 2015 Oct;138(Pt 10):2974-86. doi: 10.1093/brain/awv211. Epub 2015 Jul 14.

39.

Culturally Adapted Cognitive-Behavioral Therapy for Chinese Americans With Depression: A Randomized Controlled Trial.

Hwang WC, Myers HF, Chiu E, Mak E, Butner JE, Fujimoto K, Wood JJ, Miranda J.

Psychiatr Serv. 2015 Oct;66(10):1035-42. doi: 10.1176/appi.ps.201400358. Epub 2015 Jul 1.

40.

Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.

Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O'Brien JT.

Am J Psychiatry. 2015 Aug 1;172(8):731-42. doi: 10.1176/appi.ajp.2015.14121582. Epub 2015 Jun 18. Review.

PMID:
26085043
41.

Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease.

Mak E, Su L, Williams GB, O'Brien JT.

Parkinsonism Relat Disord. 2015 Aug;21(8):862-70. doi: 10.1016/j.parkreldis.2015.05.013. Epub 2015 May 19. Review.

PMID:
26004683
42.

[11C]PBR28 PET imaging is sensitive to neuroinflammation in the aged rat.

Walker MD, Dinelle K, Kornelsen R, Lee NV, Miao Q, Adam M, Takhar C, Mak E, Schulzer M, Farrer MJ, Sossi V.

J Cereb Blood Flow Metab. 2015 Aug;35(8):1331-8. doi: 10.1038/jcbfm.2015.54. Epub 2015 Apr 1.

43.

Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.

Mak E, Chin R, Ng LT, Yeo D, Hameed S.

Int J Geriatr Psychiatry. 2015 Dec;30(12):1207-14. doi: 10.1002/gps.4275. Epub 2015 Mar 9.

PMID:
25754519
44.

White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.

Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N.

J Neuroimaging. 2015 Sep-Oct;25(5):754-60. doi: 10.1111/jon.12230. Epub 2015 Mar 5.

PMID:
25753576
45.

Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies.

Mak E, Su L, Williams GB, Watson R, Firbank M, Blamire AM, O'Brien JT.

Neuroimage Clin. 2015 Feb 7;7:456-62. doi: 10.1016/j.nicl.2015.01.017. eCollection 2015.

46.

Microbes Promote Amino Acid Harvest to Rescue Undernutrition in Drosophila.

Yamada R, Deshpande SA, Bruce KD, Mak EM, Ja WW.

Cell Rep. 2015 Feb 17;10(6):865-872. doi: 10.1016/j.celrep.2015.01.018. Epub 2015 Feb 13.

47.

Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease.

Mak E, Su L, Williams GB, Watson R, Firbank MJ, Blamire AM, O'Brien JT.

Neurobiol Aging. 2015 Apr;36(4):1743-1750. doi: 10.1016/j.neurobiolaging.2014.12.038. Epub 2015 Jan 8.

PMID:
25649023
48.

Voices of Alzheimer Caregivers on Positive Aspects of Caregiving.

Cheng ST, Mak EP, Lau RW, Ng NS, Lam LC.

Gerontologist. 2016 Jun;56(3):451-60. doi: 10.1093/geront/gnu118. Epub 2015 Jan 21.

PMID:
25614608
49.

Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.

Hannon B, Dyck M, Pope A, Swami N, Banerjee S, Mak E, Bryson J, Rodin G, Ridley J, Lo C, Le LW, Zimmermann C.

J Pain Symptom Manage. 2015 May;49(5):945-52. doi: 10.1016/j.jpainsymman.2014.10.013. Epub 2014 Dec 15.

PMID:
25523890
50.

The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer.

Hannon B, Swami N, Pope A, Rodin G, Dougherty E, Mak E, Banerjee S, Bryson J, Ridley J, Zimmermann C.

Support Care Cancer. 2015 Apr;23(4):1073-80. doi: 10.1007/s00520-014-2460-4. Epub 2014 Oct 4.

PMID:
25281230

Supplemental Content

Support Center